Material: Phenophybate 200mg Capsules and 160 mg Tablet
Instructions: Friedrichson type IIa, IIb, III, IV and V hyperlipidemia are applied in addition to diet control in patient care.
Dimensions and Usage Rules: 1 200mg Capsule or 1 160 mg Tablet a day.
Alerts and in which cases can not be used: severe losers and liver function, circulatory primary circulation and patients whose liver function is always abnormal due to unknown, early patients' disease and those who are extremely sensitive to phenophibre.
Side effects: Hepatitis, gallstones, piles of gallstones, liver progression, muscular pain, muscular weakness, rhabdomyomycosis, light sensitivity, eczema, peripheral edema, enzina, chest rash, spinal movement and migraine.
Response to other drugs: oral antioxidants and psychosporin.
Use during pregnancy and breastfeeding: If pregnancy is more than a child's risk, then it can be used carefully during pregnancy. Nursing mothers can not be used.
āĻāĻĒাāĻĻাāύ : āĻĢেāύোāĻĢাāĻāĻŦ্āϰেāĻ ā§¨ā§Ļā§Ļ āĻŽি.āĻ্āϰা. āĻ্āϝাāĻĒāϏুāϞ āĻ ā§§ā§Ŧā§Ļ āĻŽি.āĻ্āϰা. āĻ্āϝাāĻŦāϞেāĻ ।
āύিāϰ্āĻĻেāĻļāύা : āĻĢ্āϰেāĻĄāϰিāĻāϏāύ āĻাāĻāĻĒ IIa, IIb, III, IVāĻāĻŦং V āĻšাāĻāĻĒাāϰāϞিāĻĒিāĻĄিāĻŽিāϝ়া āϰোāĻীāϰ āĻিāĻিā§āϏাāϝ় āĻাāĻĻ্āϝ āύিāϝ়āύ্āϤ্āϰāĻŖেāϰ āĻĒাāĻļাāĻĒাāĻļি āĻĒ্āϰāϝ়োāĻ āĻāϰা āĻšāϝ়।
āĻŽাāϤ্āϰা āĻ āĻŦ্āϝāĻŦāĻšাāϰ āĻŦিāϧি : ā§§āĻি ⧍ā§Ļā§Ļ āĻŽি.āĻ্āϰা. āĻ্āϝাāĻĒāϏুāϞ āĻŦা ā§§ āĻি ā§§ā§Ŧā§Ļ āĻŽি.āĻ্āϰা. āĻ্āϝাāĻŦāϞেāĻ āĻĻিāύে āĻāĻāĻŦাāϰ।
āϏāϤāϰ্āĻāϤা āĻ āϝেāϏāĻŦ āĻ্āώেāϤ্āϰে āĻŦ্āϝāĻŦāĻšাāϰ āĻāϰা āϝাāĻŦে āύা : āϝāĻৃāϤেāϰ āĻāĻŦং āĻŦৃāĻ্āĻেāϰ āϤীāĻŦ্āϰ āĻ āĻাāϰ্āϝāĻাāϰিāϤা, āĻĒ্āϰাāĻĨāĻŽিāĻ āĻŦিāϞিāϝ়াāϰী āϏিāϰোāϏিāϏ āĻāĻŦং āϝেāϏāĻŦ āϰোāĻীāϰ āϞিāĻাāϰ āĻĢাংāĻļāύ āϏāϰ্āĻŦāĻĻা āĻ āĻাāύা āĻাāϰāĻŖে āĻ āϏ্āĻŦাāĻাāĻŦিāĻ, āĻāĻে āĻĨেāĻে āĻিāϞ āĻāĻŽāύ āĻĒিāϤ্āϤāĻĨāϞিāϰ āĻ āϏুāĻ āĻāĻŦং āϝাāϰা āĻĢেāύোāĻĢাāĻāĻŦ্āϰেāĻেāϰ āĻĒ্āϰāϤি āĻ āϤিāϏংāĻŦেāĻĻāύāĻļীāϞ।
āĻĒাāϰ্āĻļ্āĻŦ āĻĒ্āϰāϤিāĻ্āϰিāϝ়া : āĻšেāĻĒাāĻাāĻāĻিāϏ, āĻĒিāϤ্āϤāĻĨāϞিāϰ āĻĒাāĻĨāϰ, āĻĒিāϤ্āϤāĻĨāϞিāϰ āĻĒ্āϰāĻĻাāĻš, āϝāĻৃāϤেāϰ āĻŦৃāĻĻ্āϧি, āĻŽাংāϏāĻĒেāĻļীāϰ āĻŦ্āϝāĻĨা, āĻŽাংāϏāĻĒেāĻļীāϰ āĻĻুāϰ্āĻŦāϞāϤা, āϰ্āϝাāĻŦāĻĄোāĻŽাāϝ়োāϞাāĻāϏিāϏ, āĻāϞোāĻ āϏংāĻŦেāĻĻāύāĻļীāϞāϤা, āĻāĻāĻিāĻŽা, āĻĒেāϰিāĻĢেāϰাāϞ āĻāĻĄিāĻŽা, āĻāύāĻিāύা, āĻŦুāĻ āϧāĻĄ়āĻĢāĻĄ়, āύাāĻĄ়ীāϰ āĻāϤি āĻŦৃāĻĻ্āϧি āĻāĻŦং āĻŽাāĻāĻ্āϰেāύ।
āĻ āύ্āϝাāύ্āϝ āĻāώুāϧেāϰ āϏাāĻĨে āĻĒ্āϰāϤিāĻ্āϰিāϝ়া : āĻāϰাāϞ āĻāύ্āĻিāĻোāϝ়াāĻুāϞেāύ্āĻ āĻāĻŦং āϏাāĻāĻোāϏ্āĻĒোāϰিāύ।
āĻāϰ্āĻাāĻŦāϏ্āĻĨা āĻ āϏ্āϤāύ্āϝāĻĻাāύāĻাāϞে āĻŦ্āϝāĻŦāĻšাāϰ : āϝāĻĻি āĻāϰ্āĻāϏ্āĻĨ āϏāύ্āϤাāύেāϰ āĻুঁāĻিāϰ āĻেāϝ়ে āĻāĻĒāĻাāϰ āĻŦেāĻļী āĻšāϝ় āϤāĻŦে āϏāϤāϰ্āĻāϤাāϰ āϏাāĻĨে āĻāϰ্āĻাāĻŦāϏ্āĻĨাāϝ় āĻŦ্āϝāĻŦāĻšাāϰ āĻāϰা āϝেāϤে āĻĒাāϰে। āύাāϰ্āϏিং āĻŽাāϝ়েāϰ āĻ্āώেāϤ্āϰে āĻŦ্āϝāĻŦāĻšাāϰ āĻāϰা āϝাāĻŦে āύা।
āĻāĻĒাāĻĻাāύ : āĻĢেāύোāĻĢাāĻāĻŦ্āϰেāĻ ā§¨ā§Ļā§Ļ āĻŽি.āĻ্āϰা. āĻ্āϝাāĻĒāϏুāϞ āĻ ā§§ā§Ŧā§Ļ āĻŽি.āĻ্āϰা. āĻ্āϝাāĻŦāϞেāĻ ।
āύিāϰ্āĻĻেāĻļāύা : āĻĢ্āϰেāĻĄāϰিāĻāϏāύ āĻাāĻāĻĒ IIa, IIb, III, IVāĻāĻŦং V āĻšাāĻāĻĒাāϰāϞিāĻĒিāĻĄিāĻŽিāϝ়া āϰোāĻীāϰ āĻিāĻিā§āϏাāϝ় āĻাāĻĻ্āϝ āύিāϝ়āύ্āϤ্āϰāĻŖেāϰ āĻĒাāĻļাāĻĒাāĻļি āĻĒ্āϰāϝ়োāĻ āĻāϰা āĻšāϝ়।
āĻŽাāϤ্āϰা āĻ āĻŦ্āϝāĻŦāĻšাāϰ āĻŦিāϧি : ā§§āĻি ⧍ā§Ļā§Ļ āĻŽি.āĻ্āϰা. āĻ্āϝাāĻĒāϏুāϞ āĻŦা ā§§ āĻি ā§§ā§Ŧā§Ļ āĻŽি.āĻ্āϰা. āĻ্āϝাāĻŦāϞেāĻ āĻĻিāύে āĻāĻāĻŦাāϰ।
āϏāϤāϰ্āĻāϤা āĻ āϝেāϏāĻŦ āĻ্āώেāϤ্āϰে āĻŦ্āϝāĻŦāĻšাāϰ āĻāϰা āϝাāĻŦে āύা : āϝāĻৃāϤেāϰ āĻāĻŦং āĻŦৃāĻ্āĻেāϰ āϤীāĻŦ্āϰ āĻ āĻাāϰ্āϝāĻাāϰিāϤা, āĻĒ্āϰাāĻĨāĻŽিāĻ āĻŦিāϞিāϝ়াāϰী āϏিāϰোāϏিāϏ āĻāĻŦং āϝেāϏāĻŦ āϰোāĻীāϰ āϞিāĻাāϰ āĻĢাংāĻļāύ āϏāϰ্āĻŦāĻĻা āĻ āĻাāύা āĻাāϰāĻŖে āĻ āϏ্āĻŦাāĻাāĻŦিāĻ, āĻāĻে āĻĨেāĻে āĻিāϞ āĻāĻŽāύ āĻĒিāϤ্āϤāĻĨāϞিāϰ āĻ āϏুāĻ āĻāĻŦং āϝাāϰা āĻĢেāύোāĻĢাāĻāĻŦ্āϰেāĻেāϰ āĻĒ্āϰāϤি āĻ āϤিāϏংāĻŦেāĻĻāύāĻļীāϞ।
āĻĒাāϰ্āĻļ্āĻŦ āĻĒ্āϰāϤিāĻ্āϰিāϝ়া : āĻšেāĻĒাāĻাāĻāĻিāϏ, āĻĒিāϤ্āϤāĻĨāϞিāϰ āĻĒাāĻĨāϰ, āĻĒিāϤ্āϤāĻĨāϞিāϰ āĻĒ্āϰāĻĻাāĻš, āϝāĻৃāϤেāϰ āĻŦৃāĻĻ্āϧি, āĻŽাংāϏāĻĒেāĻļীāϰ āĻŦ্āϝāĻĨা, āĻŽাংāϏāĻĒেāĻļীāϰ āĻĻুāϰ্āĻŦāϞāϤা, āϰ্āϝাāĻŦāĻĄোāĻŽাāϝ়োāϞাāĻāϏিāϏ, āĻāϞোāĻ āϏংāĻŦেāĻĻāύāĻļীāϞāϤা, āĻāĻāĻিāĻŽা, āĻĒেāϰিāĻĢেāϰাāϞ āĻāĻĄিāĻŽা, āĻāύāĻিāύা, āĻŦুāĻ āϧāĻĄ়āĻĢāĻĄ়, āύাāĻĄ়ীāϰ āĻāϤি āĻŦৃāĻĻ্āϧি āĻāĻŦং āĻŽাāĻāĻ্āϰেāύ।
āĻ āύ্āϝাāύ্āϝ āĻāώুāϧেāϰ āϏাāĻĨে āĻĒ্āϰāϤিāĻ্āϰিāϝ়া : āĻāϰাāϞ āĻāύ্āĻিāĻোāϝ়াāĻুāϞেāύ্āĻ āĻāĻŦং āϏাāĻāĻোāϏ্āĻĒোāϰিāύ।
āĻāϰ্āĻাāĻŦāϏ্āĻĨা āĻ āϏ্āϤāύ্āϝāĻĻাāύāĻাāϞে āĻŦ্āϝāĻŦāĻšাāϰ : āϝāĻĻি āĻāϰ্āĻāϏ্āĻĨ āϏāύ্āϤাāύেāϰ āĻুঁāĻিāϰ āĻেāϝ়ে āĻāĻĒāĻাāϰ āĻŦেāĻļী āĻšāϝ় āϤāĻŦে āϏāϤāϰ্āĻāϤাāϰ āϏাāĻĨে āĻāϰ্āĻাāĻŦāϏ্āĻĨাāϝ় āĻŦ্āϝāĻŦāĻšাāϰ āĻāϰা āϝেāϤে āĻĒাāϰে। āύাāϰ্āϏিং āĻŽাāϝ়েāϰ āĻ্āώেāϤ্āϰে āĻŦ্āϝāĻŦāĻšাāϰ āĻāϰা āϝাāĻŦে āύা।
drugs club
Fenofibrate
high cholesterol for drug
Hypercholesterolemia
hyperlipidmia medicine
āĻĢেāύোāĻĢাāĻŦ্āϰেāĻ
āĻšাāĻ āĻোāϞেāώ্āĻেāϰāϞ